Danhof M - Search Results

1

Markers of disease severity in chronic obstructive pulmonary disease.

Franciosi LG, Page CP, Celli BR, Cazzola M, Walker MJ, Danhof M, Rabe KF, Della Pasqua OE. Franciosi LG, et al. Among authors: danhof m. Pulm Pharmacol Ther. 2006;19(3):189-99. doi: 10.1016/j.pupt.2005.05.001. Epub 2005 Jul 12. Pulm Pharmacol Ther. 2006. PMID: 16019244

2

Markers of exacerbation severity in chronic obstructive pulmonary disease.

Franciosi LG, Page CP, Celli BR, Cazzola M, Walker MJ, Danhof M, Rabe KF, Della Pasqua OE. Franciosi LG, et al. Among authors: danhof m. Respir Res. 2006 May 10;7(1):74. doi: 10.1186/1465-9921-7-74. Respir Res. 2006. PMID: 16686949 Free PMC article.

3

Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers.

Huntjens DR, Spalding DJ, Danhof M, Della Pasqua OE. Huntjens DR, et al. Among authors: danhof m. Br J Pharmacol. 2006 Jun;148(4):396-404. doi: 10.1038/sj.bjp.0706737. Epub 2006 May 8. Br J Pharmacol. 2006. PMID: 16682968 Free PMC article.

4

Analysis of the relationship between age and treatment response in migraine.

Maas HJ, Danhof M, Della Pasqua OE. Maas HJ, et al. Among authors: danhof m. Cephalalgia. 2009 Jul;29(7):772-80. doi: 10.1111/j.1468-2982.2008.01823.x. Epub 2009 Mar 5. Cephalalgia. 2009. PMID: 19281474

5

From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugs.

Santen G, van Zwet E, Danhof M, Della Pasqua O. Santen G, et al. Among authors: danhof m. Clin Pharmacol Ther. 2009 Sep;86(3):248-54. doi: 10.1038/clpt.2009.105. Epub 2009 Aug 5. Clin Pharmacol Ther. 2009. PMID: 19657333 Review.

6

Bridging strategies for drug combinations in pediatric indications.

Cella M, Danhof M, Della Pasqua O. Cella M, et al. Among authors: danhof m. Clin Pharmacol Ther. 2012 Apr;91(4):726-33. doi: 10.1038/clpt.2011.298. Epub 2012 Mar 7. Clin Pharmacol Ther. 2012. PMID: 22398968

7

Prediction of disease progression, treatment response and dropout in chronic obstructive pulmonary disease (COPD).

Musuamba FT, Teutonico D, Maas HJ, Facius A, Yang S, Danhof M, Della Pasqua O. Musuamba FT, et al. Among authors: danhof m. Pharm Res. 2015 Feb;32(2):617-27. doi: 10.1007/s11095-014-1490-4. Epub 2014 Sep 18. Pharm Res. 2015. PMID: 25231008 Free PMC article. Clinical Trial.

8

A model-based approach to treatment comparison in acute migraine.

Maas HJ, Danhof M, Della Pasqua O. Maas HJ, et al. Among authors: danhof m. Br J Clin Pharmacol. 2006 Nov;62(5):591-600. doi: 10.1111/j.1365-2125.2006.02670.x. Br J Clin Pharmacol. 2006. PMID: 17061965 Free PMC article.

9

Relevance of absorption rate and lag time to the onset of action in migraine.

Maas HJ, Spruit MA, Danhof M, Della Pasqua OE. Maas HJ, et al. Among authors: danhof m. Clin Pharmacokinet. 2008;47(2):139-46. doi: 10.2165/00003088-200847020-00007. Clin Pharmacokinet. 2008. PMID: 18193920

10

Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model.

Santen G, Danhof M, Della Pasqua O. Santen G, et al. Among authors: danhof m. J Psychiatr Res. 2008 Oct;42(14):1189-97. doi: 10.1016/j.jpsychires.2007.11.009. Epub 2008 Mar 18. J Psychiatr Res. 2008. PMID: 18353370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

481 results

Search Page